Screening for Depression and Suicide Risk in Children and Adolescents: A Draft Systematic Review Update Adapted from the USPSTF Review for the Japan Preventive Services Task Force
DOI:
https://doi.org/10.51094/jxiv.4795キーワード:
Depression screening、 Suicide prevention、 Systematic review抄録
Background: Depression and suicide-related outcomes in children and adolescents are major public health concerns with potential lifelong consequences. Although the U.S. Preventive Services Task Force (USPSTF) has recommended depression screening for adolescents, evidence for suicide risk screening remains insufficient, and applicability to Japan is uncertain. To inform the Japan Preventive Services Task Force (JPPSTF), we conducted an updated systematic review, adapted from the USPSTF review, incorporating Japanese- and English-language evidence.
Methods: This update followed the USPSTF analytic framework and key questions. We evaluated evidence on the benefits and harms of screening for depression and suicide risk in children and adolescents, the accuracy of screening instruments, and the benefits and harms of treatment for screen-detected or otherwise relevant populations. We searched PubMed, the Cochrane Library, and Ichushi-Web for English- and Japanese-language studies. Two or more reviewers independently conducted study selection, data extraction, and risk-of-bias assessment, with disagreements resolved through discussion. Newly identified evidence was qualitatively synthesized with the USPSTF review to inform the Japanese context.
Results: A total of 21 studies were included. Two studies suggested that universal school-based screening improved identification of adolescents at risk and initiation of mental health services. Five studies on screening accuracy showed heterogeneous performance across instruments and settings. One study found no evidence that suicide-related screening questions increased short-term distress or suicidality. Thirteen studies of treatment interventions suggested that several psychological, digital, and school-based approaches may improve depressive symptoms and/or suicide-related outcomes, although findings wereheterogeneous. Five studies addressing treatment harms showed no consistent evidence of major short-term harm, but harms were incompletely and inconsistently reported.
Conclusions: Current evidence suggests that screening and selected treatment interventions may be beneficial for children and adolescents with depression or suicide risk, particularly when linked to appropriate follow-up and care systems. However, the evidence base remains limited, especially for suicide risk screening, harms, and applicability to Japanese preventive care settings. These findings provide an updated evidence base to support the JPPSTF in developing contextually relevant recommendations.
利益相反に関する開示
すべての著者は、利益相反がないダウンロード *前日までの集計結果を表示します
引用文献
Leone M, Kuja-Halkola R, Leval A, et al. Association of youth depression with subsequent somatic diseases and premature death. JAMA Psychiatry. 2021;78(3):302-310. doi:10.1001/jamapsychiatry.2020.3786.
Merikangas KR, Calkins ME, Burstein M, et al. Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study. Pediatrics. 2015;135(4):e927-e938. doi:10.1542/peds.2014-1444.
Siu AL; U.S. Preventive Services Task Force. Screening for depression in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(5):360-366. doi:10.7326/M15-2957.
Mangione CM, Barry MJ, Nicholson WK, et al. Screening for depression and suicide risk in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(15):1534-1542. doi:10.1001/jama.2022.16946.
Viswanathan M, Wallace IF, Middleton JC, et al. Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents: An Evidence Review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2022.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016 Oct 12;355:i4919.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529–36.
Moons KG, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med. 2019 Jan 1;170(1):51–58.
Whiting P, Savović J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016 Jan;69:225–34.
Sekhar DL, Schaefer EW, Waxmonsky JG, et al. Screening in High Schools to Identify, Evaluate, and Lower Depression Among Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(11):e2131836. doi:10.1001/jamanetworkopen.2021.31836.
Sekhar DL, Batra E, Schaefer EW, et al. Adolescent Suicide Risk Screening: A Secondary Analysis of the SHIELD Randomized Clinical Trial. J Pediatr. 2022;251:172-177. doi:10.1016/j.jpeds.2022.07.036.
Roberts RE, Lewinsohn PM, Seeley JR. Screening for adolescent depression: a comparison of depression scales. J Am Acad Child Adolesc Psychiatry. 1991;30(1):58-66. doi:10.1097/00004583-199101000-00009.
Patton GC, Coffey C, Posterino M, Carlin JB, Wolfe R, Bowes G. A computerised screening instrument for adolescent depression: population-based validation and application to a two-phase case-control study. Soc Psychiatry Psychiatr Epidemiol. 1999;34(3):166-172. doi:10.1007/s001270050129.
Dierker LC, Albano AM, Clarke GN, Heimberg RG, Kendall PC, Merikangas KR, et al. Screening for anxiety and depression in early adolescence. J Am Acad Child Adolesc Psychiatry. 2001;40(8):929-936. doi:10.1097/00004583-200108000-00015.
Cuijpers P, Boluijt P, van Straten A. Screening of depression in adolescents through the Internet: sensitivity and specificity of two screening questionnaires. Eur Child Adolesc Psychiatry. 2008;17(1):32-38. doi:10.1007/s00787-007-0631-2.
Simon GE, Stewart CC, Richards JE, Ziebell R, Lapham GT, Hoopes AJ. Accuracy of Self-Report Questionnaires and Records-Based Risk Scores to Identify Adolescents' Risk for Self-Harm. Psychiatr Serv. 2025;76(6):554-562. doi:10.1176/appi.ps.20240427.
Gould MS, Marrocco FA, Kleinman M, Thomas JG, Mostkoff K, Cote J, et al. Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial. JAMA. 2005;293(13):1635-1643.
Merry SN, Stasiak K, Shepherd M, Frampton C, Fleming T, Lucassen MFG. The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. BMJ. 2012;344:e2598. doi:10.1136/bmj.e2598.
Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 2004;61(6):577-584. doi:10.1001/archpsyc.61.6.577.
Santamarina-Perez P, Mendez I, Singh MK, Berk M, Picado M, Font E, et al. Adapted Dialectical Behavior Therapy for Adolescents with a High Risk of Suicide in a Community Clinic: A Pragmatic Randomized Controlled Trial. Suicide Life Threat Behav. 2020;50(3):652-667. doi:10.1111/sltb.12612.
Schwartz KTG, Chronis-Tuscano A, Tillman R, Whalen D, Gilbert KE, Luby J. Parent-child psychotherapy targeting emotion development: unpacking the impact of parental depression on child, parenting and engagement outcomes. Eur Child Adolesc Psychiatry. 2023;32:2491-2501. doi:10.1007/s00787-022-02093-5.
Nuñez D, Meza D, Andaur J, Robinson J, Gaete J. Reframe-IT+, an indicated preventive school-based intervention, reduces suicidal ideation among adolescents in vulnerable contexts in Chile. BMC Psychol. 2024;12:780. doi:10.1186/s40359-024-02300-9.
Tang TC, Jou SH, Ko CH, Huang SY, Yen CF. Randomized study of school-based intensive interpersonal psychotherapy for depressed adolescents with suicidal risk and parasuicide behaviors. Psychiatry Clin Neurosci. 2009;63(4):463-470. doi:10.1111/j.1440-1819.2009.01991.x.
Kowalenko N, Rapee RM, Simmons J, Wignall A, Hoge R, Whitefield K, et al. Short-term effectiveness of a school-based early intervention program for adolescent depression. Clin Child Psychol Psychiatry. 2005;10(4):493-507. doi:10.1177/1359104505056311.
Do R, Lee S, Kim JS, Cho M, Shin H, Jang M, et al. Effectiveness and dissemination of computer-based cognitive behavioral therapy for depressed adolescents: Effective and accessible to whom? J Affect Disord. 2021;282:885-893. doi:10.1016/j.jad.2020.12.177.
Wright B, Tindall L, Hargate R, Allgar V, Trépel D, Ali S. Computerised cognitive-behavioural therapy for depression in adolescents: 12-month outcomes of a UK randomised controlled trial pilot study. BJPsych Open. 2020;6(1):e5. doi:10.1192/bjo.2019.91.
Luby JL, Barch DM, Whalen D, Tillman R, Freedland KE. A randomized controlled trial of parent-child psychotherapy targeting emotion development for early childhood depression. Am J Psychiatry. 2018;175(11):1102-1110. doi:10.1176/appi.ajp.2018.18030321.
Wasserman D, Hoven CW, Wasserman C, Wall M, Eisenberg R, Hadlaczky G, et al. School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial. Lancet. 2015;385(9977):1536-1544. doi:10.1016/S0140-6736(14)61213-7.
Kitchen CEW, Tiffin P, Lewis S, Gega L, Ekers D. Innovations in Practice: A randomised controlled feasibility trial of Behavioural Activation as a treatment for young people with depression. Child Adolesc Ment Health. 2021;26(3):290-295. doi:10.1111/camh.12415.
Kennedy A, Gray C, Sheridan N, Dunn L, Stewart J, Drouin S, et al. BRAVA: A randomized controlled trial of a brief group intervention for youth with suicidal ideation and their caregivers. Child Adolesc Psychiatry Ment Health. 2025;19:78. doi:10.1186/s13034-025-00941-1.
Weersing VR, Goger P, Schwartz KTG, Baca S, Angulo F, Kado-Walton M, et al. Evidence-base update of psychosocial and combination treatments for child and adolescent depression. J Clin Child Adolesc Psychol. 2025;54(1):1-51. doi:10.1080/15374416.2024.2384022.
Sim L, Murad MH, Croarkin PE, et al. Suicide interventions for youths: a systematic review. JAMA Pediatr. 2025;179(11):1217-1224. doi:10.1001/jamapediatrics.2025.3485.
Wang S, Li Q, Lu J, et al. Treatment rates for mental disorders among children and adolescents: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(10):e2338174. doi:10.1001/jamanetworkopen.2023.38174.
ダウンロード
公開済
投稿日時: 2026-05-31 11:23:20 UTC
公開日時: 2026-07-02 01:41:24 UTC — 2026-07-03 08:47:42 UTCに更新
バージョン
- 2026-07-03 08:47:42 UTC(2)
- 2026-07-02 01:41:24 UTC(1)
改版理由
原稿は英文であったが、タイトルと抄録を日本語登録してしまったため。ライセンス
Copyright(c)2026
Takao Kaneko
Yuichi Isaji
Shunsuke Suya
Yuki Mashizume
この作品は、Creative Commons Attribution 4.0 International Licenseの下でライセンスされています。
